Press Releases

FDA ACCEPTS FOURTH MODULE FOR DOBI MEDICAL SYSTEMS' ANGIOGENESIS BASED BREAST IMAGING SYSTEM, October 23, 2002

DOBI MEDICAL SYSTEMS' BREAST IMAGING SYSTEM AWARDED MOST INNOVATIVE PRODUCT FOR 2002 BY NJTC, Company Also Recognized With "People's Choice" Award, March 14, 2002

FDA ACCEPTS THIRD MODULE FOR DOBI MEDICAL SYSTEMS' NON-INVASIVE BREAST IMAGING SYSTEM, November 19, 2001

DOBI MEDICAL RECEIVES FDA MODULE TWO ACCEPTANCE FOR BREAST CANCER DETECTION SYSTEM, October 8, 2001

DOBI MEDICAL SYSTEMS SUBMITS THIRD  MODULE IN FDA APPLICATION PROCESS FOR ITS NON-INVASIVE BREAST IMAGING SYSTEM, August 8,2001

DOBI MEDICAL SYSTEMS NAMES LEADING ANGIOGENESIS EXPERT TO ITS SCIENTIFIC ADVISORY GROUP, July 24, 2001

DOBI MEDICAL SYSTEMS SUBMITS SECOND MODULE TO FDA FOR PRE-MARKET APPROVAL APPLICATION, June 21, 2001

DOBI MEDICAL SYSTEMS EXPANDS SENIOR MANAGEMENT TEAM, April 18, 2001

vitamix promotion code . Carpet Cleaning Spring Valley CA . ab rocket twister funziona

DOBI MEDICAL SYSTEMS AWARDED ISO 9001/EN ISO 9001/EN46001/CE MARK CERTIFICATIONS, January 31, 2001

DR. DAVID CHERESH TO LEAD DOBI MEDICAL SYSTEMS' SCIENTIFIC ADVISORY BOARD, January 29, 2001

DOBI MEDICAL SYSTEMS SHOWCASES NEW BREAST CANCER DIAGNOSTIC IMAGING SYSTEM, December 8, 2000

DOBI MEDICAL SYSTEMS SPONSORS AMERICAN ASSOCIATION FOR CANCER RESEARCH ANGIOGENESIS AND CANCER CONFERENCE, October 9, 2000

 

DOBI MEDICAL SYSTEMS TO APPEAR ON ALEXANDER HAIG'S WORLD BUSINESS REVIEW

MAHWAH, NJ, December 29, 2000 --- DOBI Medical Systems, LLC announced today that the Company and its new breast cancer diagnostic technology would be featured on the widely recognized television program, World Business Review beginning in January 2001. The television series focuses on leading edge businesses and their associated technology and is hosted by General Alexander Haig, former Secretary of State for President Reagan and former COO and President of United Technologies Corporation. DOBI Medical Systems was selected to appear for its leadership in the diagnostic field of non-invasive breast cancer detection.

DOBI Medical's Chief Executive Officer, Phillip C. Thomas will appear on General Haig's World Business Review to explain the needs and advantages of non-invasive breast cancer diagnosis and highlights new advances being made in this exciting new area of medical technology.

The DOBI System is designated an investigational device at this time and may be used only for research purposes in the U.S. pending FDA approval. Use abroad is also subject to the regulations of the respective country. Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties.

The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to, technical risks associated with new technology development, government regulatory approval, market acceptance of our product, competition and technological change.

For further information, please contact:
Phillip C. Thomas, Chief Executive Officer, 201-760-6464, pct@igaot.pt

 

DOBI Medical Systems
1200 MacArthur Blvd.
Mahwah, New Jersey 07430
Voice: (201) 760 6464
Fax: (201) 760 8860
e-mail: info@igaot.pt


Investigational Device: Limited by Federal Law to Investigational Use Only. Copyright ©2000-2001 DOBI Medical Systems All Rights Reserved.